- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 92,010 | 01.07.24 17:35:51 | +1,840 | +2,04% | 0,000 | 0,000 | 91,250 | 90,170 |
|
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.057,020 | 01.07.24 22:00:09 | +5,990 | +0,57% | 1.021,000 | 1.057,020 | 1.054,810 | 1.051,030 |
